Dysfunctional neuro-muscular mechanisms explain gradual gait changes in prodromal spastic paraplegia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Dysfunctional neuro-muscular mechanisms explain gradual gait changes in prodromal spastic paraplegia ; volume:20 ; number:1 ; day:15 ; month:7 ; year:2023 ; pages:1-19 ; date:12.2023
Journal of neuroEngineering and rehabilitation ; 20, Heft 1 (15.7.2023), 1-19, 12.2023
- Creator
-
Lassmann, Christian
Ilg, Winfried
Rattay, Tim W.
Schöls, Ludger
Giese, Martin
Haeufle, Daniel F. B.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12984-023-01206-8
- URN
-
urn:nbn:de:101:1-2023102408485231051390
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lassmann, Christian
- Ilg, Winfried
- Rattay, Tim W.
- Schöls, Ludger
- Giese, Martin
- Haeufle, Daniel F. B.
- SpringerLink (Online service)
Other Objects (12)
Translational research approaches in hereditary spastic paraplegia
Early-onset hereditary spastic paraplegia: case report
Neurometabolic Dysfunction in SPG11 Hereditary Spastic Paraplegia
New spastic paraplegia phenotype associated to mutation of NFU1
Understanding disease modulators of SPG11‐linked hereditary spastic paraplegia.
Gene identification in Hereditary Spastic Paraplegias and characterization of Spastic Paraplegia type 58 (SPG58)
Neuroinflammatory disease signatures in SPG11-related hereditary spastic paraplegia patients
Hereditary spastic paraplegia from 1880 to 2017: an historical review
The role of inflammation in hereditary spastic paraplegia type 11
Non-pharmacological treatment of hereditary spastic paraplegia: a systematic review
Functional characterization of hereditary spastic paraplegia proteins spastin and ZFYVE27
Molecular analysis of the autosomal dominant spastic paraplegia type IV (SPG4)
Translational research approaches in hereditary spastic paraplegia
Early-onset hereditary spastic paraplegia: case report
Neurometabolic Dysfunction in SPG11 Hereditary Spastic Paraplegia
New spastic paraplegia phenotype associated to mutation of NFU1
Understanding disease modulators of SPG11‐linked hereditary spastic paraplegia.
Gene identification in Hereditary Spastic Paraplegias and characterization of Spastic Paraplegia type 58 (SPG58)
Neuroinflammatory disease signatures in SPG11-related hereditary spastic paraplegia patients
Hereditary spastic paraplegia from 1880 to 2017: an historical review
The role of inflammation in hereditary spastic paraplegia type 11
Non-pharmacological treatment of hereditary spastic paraplegia: a systematic review
Functional characterization of hereditary spastic paraplegia proteins spastin and ZFYVE27
Molecular analysis of the autosomal dominant spastic paraplegia type IV (SPG4)
Translational research approaches in hereditary spastic paraplegia
Early-onset hereditary spastic paraplegia: case report
Neurometabolic Dysfunction in SPG11 Hereditary Spastic Paraplegia
New spastic paraplegia phenotype associated to mutation of NFU1
Understanding disease modulators of SPG11‐linked hereditary spastic paraplegia.
Gene identification in Hereditary Spastic Paraplegias and characterization of Spastic Paraplegia type 58 (SPG58)
Neuroinflammatory disease signatures in SPG11-related hereditary spastic paraplegia patients
Hereditary spastic paraplegia from 1880 to 2017: an historical review
The role of inflammation in hereditary spastic paraplegia type 11
Non-pharmacological treatment of hereditary spastic paraplegia: a systematic review
Functional characterization of hereditary spastic paraplegia proteins spastin and ZFYVE27